Healthcare -
Biotechnology - NASDAQ - US
$ 54.54
-0.22 %
$ 3.35 B
Market Cap
-12.62
P/E
Price Target
Average
18.39%
Revenue Forecast
Estimate
132.28%
EBIT
Estimate
--1.73%
Net Income
Estimate
56.95%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Rhythm Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for RYTM of $64.6 , with forecasts ranging from
a
low of
$55 to a high of $80 .
RYTM Lowest Price Target
Wall Street Target
55 USD
0.84%
RYTM Average Price Target
Wall Street Target
64.6 USD
18.39%
RYTM Highest Price Target
Wall Street Target
80 USD
46.68%
REVENUE FORECAST
Revenue Forecast Chart RYTM
EBIT FORECAST
EBIT Forecast Chart RYTM
NET INCOME FORECAST
Net Income Chart RYTM